Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

BACKGROUND: Recent studies have demonstrated the feasibility of combining oxaliplatin with 5-FU or capecitibine and radiation therapy (RT). The addition of bevacizumab to chemotherapy improves overall survival for metastatic disease. We initiated a phase II trial to evaluate preoperative capecitabin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Landry, Jerome C., Feng, Yang, Cohen, Steven J., Staley, Charles A., Whittington, Richard, Sigurdson, Elin Ruth, Nimeiri, Halla, Verma, Udit, Prabhu, Roshan S., Benson, Al Bowen
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3620731/
https://ncbi.nlm.nih.gov/pubmed/23288663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27890
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados